- Abstract Submission Format
Please read the following section before submitting your abstract for review. View examples of MDS abstracts.
Please limit the total abstract text to 2,500 characters (including spaces). The size limit includes Abstract Title and Abstract Body. Please refrain from using special characters within the abstract text.
- Abstracts should adhere to the following format:
- Objective (250 characters)
- Background (250 characters)
- Methods (750 characters)
- Results (750 characters)
- Conclusions (750 characters)
You will be asked to list the name, affiliation and e-mail for each co-author. However, all communications and notifications regarding abstract submissions will be sent only to the submitting author.
You may upload up to three files. The size limit for each file is 4MB.
The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands. Non-proprietary (generic) drug names should be used and should be written without capitals.
If you are including tables or figures within your abstract, you must enter the appropriate ID tag in the abstract body where you would like your tables and/or figures to appear. Tags must be entered as shown - [table1] for your first table; [table2] for your second table; [figure1] for your first figure; [figure2] for your second figure. You may upload the tables within the abstract submission system.
- Attendance is Required
Accepted abstract presenters must be in attendance at the AOPMC Congress in Hangzhou, China to present their poster(s), and should plan to attend from April 12-14, 2019, as poster presentation dates are subject to change.
Registration for the 6th AOPMC Congress will open November 5, 2018.
Please do not submit an abstract unless you are prepared to travel to the 6th AOPMC Congress April 12-14, 2019 to present your research.
- Changes to Abstract
Changes After Abstract Has Been Submitted Are Strongly Discouraged! If critical changes need to be made to your abstract content after it has been submitted, please request those changes by email to firstname.lastname@example.org.
Changes to your submitted abstract will not be accepted after October 1, 2018.
Abstracts accepted for presentation will be published in an electronic supplement to the Movement Disorders journal, online edition.
- Review Process
The AOPMC Congress Scientific Program Committee will review all abstracts. Authors are required to select one category under which their abstract should be reviewed.
The Committee shall be directed to reject abstracts for the following causes:
- Plagiarism Detected
- Subject not related to the field of Movement Disorders
- Does not meet basic submission requirements
- Terms and Conditions
MDS expects that all abstracts selected for presentation will be presented by the original author(s) and that no submitted abstracts will be withdrawn. Please do not submit an abstract if you are not prepared to travel to the meeting and present it in the session selected by MDS.
Accepted abstract presenters should plan to attend the AOPMC Congress April 12-14, 2019, as poster presentation dates are subject to change.
MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or of the group. Should plagiarism be detected, the abstract will be rejected.
All abstracts accepted for presentation may be published in an electronic supplement to the Movement Disorders journal, in the online edition.
All submitted abstracts become the property of MDS.
Withdrawing a Submitted or Accepted Abstract
If an abstract must be withdrawn for any reason, please contact email@example.com as soon as possible. There is no penalty to withdraw your abstract, however if your withdrawal request is received after the abstracts have been sent for publication, it cannot be withdrawn and will remain a part of the 2019 MDS published abstracts. All submitted abstracts become the property of MDS.